Hasta La Gadget!

If you’re looking for an iPad that’s more affordable than cutting-edge, Amazon has the 2021 base model for only $199. Although that’s a generation behind the current version, this ninth-generation edition could be great for kids, seniors or those wanting a HomeKit-based smart home hub.

The three-year-old model is still a capable tablet for anyone content with forgoing the latest and greatest hardware. The ninth-gen iPad has a 10.2-inch Retina display and Apple’s old home button-based Touch ID sensor. It runs on the A13 Bionic chip, which has a six-core processor, quad-core GPU and octal-core Neural Engine. This isn’t the model to get if you want screaming-fast speeds, the most eye-popping display or the upcoming Apple Intelligence, but it’s hard to nitpick too much about any of that when you look at the price.

Engadget’s 2021 review found this model to be “a modest update” over the previous version. Nathan Ingraham described it as “a fast, lightweight tablet with a nice display and tons of apps, without having to spend too much.” In our battery test, we found that it outperformed Apple’s 10-hour estimate, lasting about 14 hours of video streaming.

This model runs iPadOS 17 and will support iPadOS 18 when it launches this fall. It isn’t known how many annual updates it will be eligible for after that, but the upcoming 2024 software will still run on two hardware generations behind this model, hinting that it may not be approaching the end of the line just yet.

It’s also well-suited for video chat, and its 12MP ultrawide front-facing camera supports Center Stage. Apple’s machine learning-based feature tracks your and anyone else’s faces in the shot, adjusting the call’s framing accordingly through automatic pans and zooms.

If you want to add accessories for a more laptop-like experience, the ninth-gen iPad is compatible with the first-generation Apple Pencil and Apple Smart Keyboard.

Nathan Ingraham for Engadget

It’s worth keeping in mind that this model uses a Lightning connector rather than the USB-C that Apple has shifted its product lineup toward. It includes a charger in the box, but you may want to consider that if you’ve already chucked all your old Lightning cables. On the other hand, some may consider it a bonus that it still includes Apple’s now-defunct headphone jack.

This article originally appeared on Engadget at https://www.engadget.com/mobile/tablets/apples-ninth-generation-ipad-hits-an-all-time-low-of-199-191018362.html?src=rss

If you’re looking for an iPad that’s more affordable than cutting-edge, Amazon has the 2021 base model for only $199. Although that’s a generation behind the current version, this ninth-generation edition could be great for kids, seniors or those wanting a HomeKit-based smart home hub.

The three-year-old model is still a capable tablet for anyone content with forgoing the latest and greatest hardware. The ninth-gen iPad has a 10.2-inch Retina display and Apple’s old home button-based Touch ID sensor. It runs on the A13 Bionic chip, which has a six-core processor, quad-core GPU and octal-core Neural Engine. This isn’t the model to get if you want screaming-fast speeds, the most eye-popping display or the upcoming Apple Intelligence, but it’s hard to nitpick too much about any of that when you look at the price.

Engadget’s 2021 review found this model to be “a modest update” over the previous version. Nathan Ingraham described it as “a fast, lightweight tablet with a nice display and tons of apps, without having to spend too much.” In our battery test, we found that it outperformed Apple’s 10-hour estimate, lasting about 14 hours of video streaming.

This model runs iPadOS 17 and will support iPadOS 18 when it launches this fall. It isn’t known how many annual updates it will be eligible for after that, but the upcoming 2024 software will still run on two hardware generations behind this model, hinting that it may not be approaching the end of the line just yet.

It’s also well-suited for video chat, and its 12MP ultrawide front-facing camera supports Center Stage. Apple’s machine learning-based feature tracks your and anyone else’s faces in the shot, adjusting the call’s framing accordingly through automatic pans and zooms.

If you want to add accessories for a more laptop-like experience, the ninth-gen iPad is compatible with the first-generation Apple Pencil and Apple Smart Keyboard.

Nathan Ingraham for Engadget

It’s worth keeping in mind that this model uses a Lightning connector rather than the USB-C that Apple has shifted its product lineup toward. It includes a charger in the box, but you may want to consider that if you’ve already chucked all your old Lightning cables. On the other hand, some may consider it a bonus that it still includes Apple’s now-defunct headphone jack.

This article originally appeared on Engadget at https://www.engadget.com/mobile/tablets/apples-ninth-generation-ipad-hits-an-all-time-low-of-199-191018362.html?src=rss

Zoom just announced that webinar calls can now support up to one million simultaneous participants. This is happening after various political groups used the video conferencing platform to raise money for Vice President Kamala Harris’ election campaign, often by hosting calls with hundreds of thousands of people.

The company now offers various tiers to accommodate large events. Customers can choose from webinars that feature max capacities of 10K, 50K, 100K, 250K, 500K, and, of course, 1M attendees. These are single-use webinar packages that come with support from Zoom’s Event Services team to ensure a “professional, engaging experience” for all.

“Now event organizers have the flexibility and power to host truly interactive experiences on an unprecedented scale and the ability to purchase large single-use webinars,” said Smita Hashim, chief product officer at Zoom.

Despite being recently used for political fundraising, Zoom envisions a future in which these large-scale virtual events are common across the enterprise, entertainment and public sectors. The company says, for instance, that celebrities and entertainers can use these webinar capabilities to host fan meet-and-greets and other kinds of virtual events.

These events, however, don’t come cheap. Booking a one-time webinar for a million people will set you back a cool $100,000. That’s actually a good deal, as a webinar for 10,000 people costs $9,000, which is almost a dollar per person.

Before this change, Zoom only offered official support for up to 100,000 attendees. However, reporting by Bloomberg indicates that the company recently changed course so as to accommodate the aforementioned fundraising events.

This all started in July when an organization called Win with Black Women held a Zoom call with more than 40,000 attendees in which they raised $1.5 million for the Harris campaign. This was followed by White Dudes for Harris, with 190,000 attendees, and White Women for Harris, with 164,000 attendees.

This could be a lucrative new revenue source for Zoom. After all, it wasn’t so long ago that its stock sold for $560 per share before dropping to around $60 per share. This rapid decline was expected, as the world moved on from virtual meetings and started going outside again.

This article originally appeared on Engadget at https://www.engadget.com/social-media/zoom-can-now-handle-one-million-simultaneous-participants-170919609.html?src=rss

Neptune Medical recently secured $97 million in Series D financing and launched a subsidiary, Jupiter Endovascular Inc., marking a strategic move to enhance its focus on gastrointestinal (GI) robotics while enabling Jupiter to advance in endovascular treatments. Neptune’s founder and CEO, Alex Tilson, emphasized that these developments will allow both companies to innovate within their respective fields.

The formation of Jupiter Endovascular follows Neptune’s recent appointment of Dr. Fred Moll, a surgical robotics pioneer, as chair of its board. Moll described the spinout as a strategic decision that will provide Jupiter with the resources and leadership needed to revolutionize endovascular therapies, while Neptune continues to focus on breakthroughs in GI robotics.

Jupiter Endovascular is pioneering a new generation of endovascular procedures with its Endoportal Control technology. (Source: Jupiter Endovascular)

Jupiter Endovascular exited stealth mode with $21 million in new financing and is developing the Endoportal Control platform. This technology aims to provide the precision of direct surgical access in catheter-based surgeries, enhancing the stability and control required in complex cardiovascular procedures. The company plans to use its new funding for an upcoming pivotal trial focused on pulmonary embolism, as well as for expanding the clinical applications of its technology.

Carl J. St. Bernard, recently appointed CEO of Jupiter Endovascular, highlighted the potential of the Endoportal Control technology to transform cardiovascular treatment by offering a minimally invasive yet highly controlled approach to delivering therapies.

The financing rounds for Neptune and Jupiter were supported by investors such as Sonder Capital and Olympus Corporation of the Americas. Sonder Capital’s managing partner, Kate Garrett, noted that Jupiter’s innovative approach could address significant unmet clinical needs, particularly in treating diseases in complex cardiovascular anatomies. Sonder Capital, co-founded by Moll, has a history of investing in healthcare technology companies, including Intuitive Surgical and Auris Medical.

Use case scenarios

The Endoportal Control technology from Jupiter Endovascular could have several impactful use case scenarios:

• Pulmonary Embolism Treatment: The technology could offer precise control in catheter-based procedures to remove blood clots in the lungs, reducing risks associated with traditional surgeries.
• Aortic Aneurysm Repair: By enhancing stability and precision, Endoportal Control could improve the accuracy of stent placements in the treatment of aortic aneurysms.
• Coronary Artery Disease: The technology could allow for more controlled and minimally invasive interventions in treating blocked coronary arteries, potentially improving outcomes for patients with heart disease.
• Complex Cardiovascular Procedures: It could be used in challenging cases involving intricate or hard-to-reach cardiovascular anatomies, providing the precision needed to safely deliver treatments.
• Stroke Intervention: Endoportal Control might facilitate the removal of clots from the brain’s arteries, improving the effectiveness of stroke interventions and reducing the risk of damage during the procedure.

These scenarios highlight the potential for Endoportal Control to transform how complex cardiovascular conditions are treated, making procedures safer and more effective.

Neptune Medical Raises $97M, Launches Jupiter Endovascular

, original content from Ubergizmo. Read our Copyrights and terms of use.

Neptune Medical recently secured $97 million in Series D financing and launched a subsidiary, Jupiter Endovascular Inc., marking a strategic move to enhance its focus on gastrointestinal (GI) robotics while enabling Jupiter to advance in endovascular treatments. Neptune’s founder and CEO, Alex Tilson, emphasized that these developments will allow both companies to innovate within their respective fields.

The formation of Jupiter Endovascular follows Neptune’s recent appointment of Dr. Fred Moll, a surgical robotics pioneer, as chair of its board. Moll described the spinout as a strategic decision that will provide Jupiter with the resources and leadership needed to revolutionize endovascular therapies, while Neptune continues to focus on breakthroughs in GI robotics.

Jupiter Endovascular is pioneering a new generation of endovascular procedures with its Endoportal Control technology. (Source: Jupiter Endovascular)

Jupiter Endovascular exited stealth mode with $21 million in new financing and is developing the Endoportal Control platform. This technology aims to provide the precision of direct surgical access in catheter-based surgeries, enhancing the stability and control required in complex cardiovascular procedures. The company plans to use its new funding for an upcoming pivotal trial focused on pulmonary embolism, as well as for expanding the clinical applications of its technology.

Carl J. St. Bernard, recently appointed CEO of Jupiter Endovascular, highlighted the potential of the Endoportal Control technology to transform cardiovascular treatment by offering a minimally invasive yet highly controlled approach to delivering therapies.

The financing rounds for Neptune and Jupiter were supported by investors such as Sonder Capital and Olympus Corporation of the Americas. Sonder Capital’s managing partner, Kate Garrett, noted that Jupiter’s innovative approach could address significant unmet clinical needs, particularly in treating diseases in complex cardiovascular anatomies. Sonder Capital, co-founded by Moll, has a history of investing in healthcare technology companies, including Intuitive Surgical and Auris Medical.

Use case scenarios

The Endoportal Control technology from Jupiter Endovascular could have several impactful use case scenarios:

• Pulmonary Embolism Treatment: The technology could offer precise control in catheter-based procedures to remove blood clots in the lungs, reducing risks associated with traditional surgeries.
• Aortic Aneurysm Repair: By enhancing stability and precision, Endoportal Control could improve the accuracy of stent placements in the treatment of aortic aneurysms.
• Coronary Artery Disease: The technology could allow for more controlled and minimally invasive interventions in treating blocked coronary arteries, potentially improving outcomes for patients with heart disease.
• Complex Cardiovascular Procedures: It could be used in challenging cases involving intricate or hard-to-reach cardiovascular anatomies, providing the precision needed to safely deliver treatments.
• Stroke Intervention: Endoportal Control might facilitate the removal of clots from the brain’s arteries, improving the effectiveness of stroke interventions and reducing the risk of damage during the procedure.

These scenarios highlight the potential for Endoportal Control to transform how complex cardiovascular conditions are treated, making procedures safer and more effective.

Neptune Medical Raises $97M, Launches Jupiter Endovascular

, original content from Ubergizmo. Read our Copyrights and terms of use.